Metreleptin
Myalept, Myalepta (metreleptin) is a protein pharmaceutical. Metreleptin was first approved as Myalept on 2014-02-24. It is used to treat lipodystrophy in the USA. It has been approved in Europe to treat familial partial lipodystrophy.
Trade Name | Myalepta |
---|---|
Common Name | Metreleptin |
Indication | familial partial lipodystrophy, lipodystrophy |
Drug Class | Leptin derivatives |
